Recent Articles

Daily cup of coffee may prevent afib recurrence

Gene-editing therapy lowers harmful blood fats in early study

What is EMDR therapy, and who can it help?

GLP-1 drugs versus bariatric surgery for treating obesity

Trying to lose weight? Be careful not to lose muscle

Two dumbbells, three exercises, and 10 minutes

Easing the emotional burden of IBS

Modify your push-ups to meet your fitness level

What is long QT syndrome?

Stroke survivors may benefit from very low LDL levels

Adam Kibel, MD, MHCM

Editorial Advisory Board Member, Harvard Health Publishing

Adam Kibel, MD, MHCM, is the chief of urology at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, and the Elliott Carr Cutler Professor of Surgery at Harvard Medical School. He received his BA and MD from Cornell University in 1987 and 1991 respectively. He then completed his residency at the Harvard Program in Urology (Longwood) in 1997, and a fellowship in urologic oncology at Johns Hopkins in 1999. In 2022, he received a master’s in health care management from Harvard University.

His practice focuses on minimally invasive approaches to urologic cancers. He has over 400 peer-reviewed publications, and has received grant support from multiple agencies, including the National Cancer Institute, the American Urologic Association, the American College of Surgeons, and the Department of Defense. The focus of his research is on identification and treatment of patients with aggressive genitourinary cancers though neoadjuvant therapy, improved imaging, and novel biomarkers.